Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 4/20 | 0.40 |
| ▸ | HTR7 | P34969 | 2/20 | 0.40 |
| ▸ | HTR6 | P50406 | 2/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 7/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TTK | P33981 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16675985 | 0.80 | HTR1A (0.43) | HTR1AHTR7HTR6NTRK1MAPK8 | |
| SCHEMBL30713502 | 0.79 | ALOX5AP (0.32) | — | |
| SCHEMBL31411331 | 0.77 | GPR84 (0.39) | HTR7HTR6NTRK1MAPK8GRM4 | |
| SCHEMBL31411291 | 0.77 | GRM4 (0.33) | GRM4 | |
| SCHEMBL14631557 | 0.76 | HTR2A (0.50) | HTR6MAPK8HTR2AMAPK10TTK | |
| SCHEMBL1967068 | 0.75 | PRKAA1 (0.46) | HTR1AHTR7HTR6NTRK1LMNA | |
| SCHEMBL20764903 | 0.74 | HTR1A (0.35) | HTR1AHTR7HTR6 | |
| SCHEMBL14631436 | 0.74 | GAA (0.37) | HTR1AHTR7HTR6GRM4 | |
| SCHEMBL31411308 | 0.73 | MAPT (0.35) | GRM4LMNARAB9AMAPK10SMN1; SMN2 | |
| SCHEMBL31411324 | 0.73 | F10 (0.34) | NTRK1MAPK8GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735425-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-20250353818-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-11-20 | — | — | US | disclosed |
| US-12428380-B2 | Compounds | Psylo Pty Ltd (AU) | 2025-09-30 | — | — | US | disclosed |
| US-20250214943-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-07-03 | — | — | US | disclosed |
| WO-2025000053-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214943-A1 | Compounds | NLN, SLC18A2, PYGB | HTR1A 185/4885HTR7 192/4885HTR6 54/4885 |
| US-12428380-B2 | Compounds | NLN, SLC18A2, PYGB | HTR1A 185/4885HTR7 192/4885HTR6 54/4885 |
| US-20250353818-A1 | Compounds | NLN, SLC18A2, PYGB | HTR1A 185/4885HTR7 192/4885HTR6 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.